Diode Laser Therapy System (PZ-BDT67-01, PZ-BDT67-02)
Zhengzhou PZ Laser Slim Technology Co., Ltd. · Decision date Sep 17, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 17, 2026 for K261817, the Diode Laser Therapy System, models PZ-BDT67-01 and PZ-BDT67-02, submitted by Zhengzhou PZ Laser Slim Technology Co., Ltd. The device is a Class II powered laser surgical instrument under 21 CFR 878.4810, product code GEX, in the General and Plastic Surgery panel. A substantial equivalence determination is a clearance, not a premarket approval.
The two models share intended use, mechanism of action and principle; the summary states they differ only in the energy-density step size on the instrument interface, 1 J/cm² for PZ-BDT67-01 and 2 J/cm² for PZ-BDT67-02. The listed predicate is K251329 (RiSu Medical Technology, RF3120-BI), with K222064 (Alma Soprano Titanium) identified as a reference device. The summary reports no clinical study and cites non-clinical testing to listed IEC and ISO standards.
The summary's intended-use text covers dermatological procedures requiring coagulation, with SHR mode for temporary hair reduction and HR mode for benign vascular and vascular dependent lesions; the comparison table also mentions an SHR Stack Mode, a discrepancy the source does not resolve. The database lists a June 1, 2026 receipt date while the cover letter states August 18, 2026. No clinical performance data are provided.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 17, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261817
- Regulatory pathway
- 510(k) premarket notification
- Product code
- GEX
- Decision code
- SESE
- Decision date
- Sep 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Laser Surgical Instrument.
- Product code
- GEX
- FDA device class
- 2
FDA decision timeline
K261817 received
Application receipt date recorded by FDA.
K261817 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Single Use Optical FiberK262886 | Quanta System Spa | 510(k) clearance | Nov 5, 2026 | FDA |
| Borze, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Risu Medical Technology Co., Ltd. | 510(k) clearance | Oct 27, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Beijing Sea Heart International Science and Technologyco.Ltd | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zhengzhou PZ Laser Slim Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Zhengzhou
Sources and methodology
- Original FDA record: K261817
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


